EVA PHARMA FOR PHARMACEUTICALS AND MEDICAL APPLIANCES S.A.E

Quantoom Biosciences and TechInvention Lifecare have signed an MoU to collaborate on RNA-based vaccine development, aiming to improve accessibility and affordability in India through Quantoom's N-Force toolbox platform.

EVA Pharma, DNA Script, and Quantoom Biosciences forge a groundbreaking partnership to develop the first digital-to-biologics mRNA production platform, targeting 100 million vaccine doses annually.

The Egyptian Drug Authority has approved Lilly and EVA Pharma's human insulin glargine injection for treating type 1 and type 2 diabetes.